Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
27 Cards in this Set
- Front
- Back
|
Nucynta Dosing Ranges? Safe Range? Frequency? Cautions? |
Tapentadol 50, 75, 100 mg No more than 500 mg/day 4-6 hrs/day |
|
|
Nucynta ER Dosing Ranges? Safe Range? Frequency? Cautions?
|
Tapentadol ER No more than 500 mg/day Patients can be converted from Nucynta tablets to ER using the equivalent total daily dose of Nucynta tablets and dividing it into two equal doses of Nucynta ER separated by approx 12 hr intervals. As an example, a pt receiving 50 mg of Nucynta tabs 4 x /day (200 mg/day) may be converted to 100 mg Nucynta ER bid. |
|
|
Xtampza Dosing Ranges? Safe Range? Frequency? Cautions? |
Abuse deterrent Oxycodone 36 mg q 12 h Oxycodone 9mg, 13.5mg, 18mg, 27mg, 36mg; ext-rel caps |
|
|
Avinza
|
Morphine Sulfate Extended Release 30-40 mg po bid |
|
|
Hysingla |
hydrocodone 80 mg q 24 h |
|
|
Embeda |
The starting dose for patients who are not opioid tolerant is EMBEDA 20 mg/0.8 mg orally every 24 hours. Patients who are opioid tolerant are those receiving, for one week or longer, at least 60 mg oral morphine per day, 25 mcg transdermal fentanyl per hour, 30 mg oral oxycodone per day, 8 mg oral hydromorphone per day, 25 mg oral oxymorphone per day, or an equianalgesic dose of another opioid.
|
|
|
Butrans |
Buprenorphine Transdermal System q 7 days 20 mcg |
|
|
Dolophine |
Methadone usually 10 mg up to 100 mg total/day |
|
|
Fentanyl Transdermal System Typical dose |
25 mcg |
|
|
Zohydro ER |
hydrocodone 40 mg q 12 h |
|
|
Exalgo |
hydromorphone hydrochloride extended release capsules 32 mg/day |
|
|
Kadian |
morphine sulfate extended release tablets 40 mg/day |
|
|
Lorcet |
hydrocodone containing acetaminophen |
|
|
MS Contin |
Morphine Sulfate Controlled release tablets |
|
|
Norco |
hydrocodone containing acetaminophen |
|
|
Oxyconitn 40 mg |
oxycodonehydrochloride controlled release tablets |
|
|
Roxicet |
Oxycodone |
|
|
Tylenol #3 |
q 6 hrs |
|
|
Lucemyra |
Lofexidine tablets 0.18 mg mitigation of opiod withdrawal symptoms to facilitate abrupt opiod discontinuation in adults |
|
|
Caution with Methadone |
EKG baseline yearly EKG due to QTC don't increase/decrease more than 20 mg q 2 weeks |
|
|
Belbuca |
buprenorphine buccal increase q 4 days Iitiate treatment in opioid naïve patients with a 75 mcg film once daily or, if tolerated, every 12 hours for at least 4 days, then increase dose to 150 mcg every 12 hours. Individual titration to a dose that provides adequate analgesia and minimizes adverse reactions should proceed in increments of 150 mcg every 12 hours, no more frequently than every 4 days. |
|
|
Relistor 150 mg |
3 tabs at once OIC (methylnaltrexone bromide) Tell your healthcare provider if you have any stomach or bowel (intestines) problems, including stomach ulcer, Crohn’s disease, diverticulitis, cancer of the stomach or bowel, or Ogilvie’s syndrome. |
|
|
OIC meds, but pts can suffer adverse GI symptoms |
Movantik Symbroic |
|
|
Ztildo |
lidocaine topical system 1.8% |
|
|
Kristalose |
Lactulose |
|
|
Amrix |
Amrix 5 mg Extended release cyclobenzaprine |
|
|
Oxymorphone hydrochloride |
oxymorphine hydrochloride extended release tablets 5-7 1/2 q6 hrs |
